Edition:
United Kingdom

Misonix Inc (MSON.OQ)

MSON.OQ on NASDAQ Stock Exchange Global Market

9.70USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$9.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,114
52-wk High
$12.00
52-wk Low
$7.05

Chart for

About

Misonix, Inc. designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company's products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.13
Market Cap(Mil.): $94.51
Shares Outstanding(Mil.): 9.36
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Misonix reports first quarter financial results

* Misonix reports first quarter fiscal year 2018 financial results

08 Nov 2017

BRIEF-Misonix Inc's revenue for Q1 was $7.3 mln

* Misonix Inc - revenue for Q1 was $7.3 million, an increase of 18pct compared with $6.2 million in the previous year’s first quarter‍​

07 Nov 2017

BRIEF-MISONIX ENTERS INTO $11 MILLION LICENSE, ROYALTY AND MANUFACTURING AGREEMENT

* MISONIX INC - ‍ENTERED INTO A LICENSE AND EXCLUSIVE MANUFACTURING AGREEMENT WITH HUNAN XING HANG RUI KANG BIO-TECHNOLOGIES CO LTD.​

20 Oct 2017

BRIEF-Misonix appoints Joseph Dwyer as chief financial officer

* Misonix Inc - ‍Dwyer has been serving as interim chief financial officer of Misonix since September 2016​ Source text for Eikon: Further company coverage:

23 Aug 2017

BRIEF-Misonix reports fiscal year 2017 financial results

* Misonix Inc - ‍for Q4, net sales increased 23% to $7.9 million compared with $6.4 million in Q4 of fiscal 2016​

22 Aug 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $142.89 --
Medtronic PLC (MDT.N) $81.92 --
Stryker Corporation (SYK.N) $153.31 --

Earnings vs. Estimates